+ All Categories
Home > News & Politics > Covering Cancer Treatments: Tricks of the Trade

Covering Cancer Treatments: Tricks of the Trade

Date post: 08-Sep-2014
Category:
Upload: ivan-oransky
View: 804 times
Download: 2 times
Share this document with a friend
Description:
One of two talks I gave at Cancer Research in the Media: The NCI’s 2nd Annual Inter-American Workshop for Scientific Journalism
Popular Tags:
20
Covering Cancer Treatment: Tricks of the Trade Ivan Oransky, MD Executive Editor, Reuters Health Cancer Research in the Media Inter-American Workshop for Scientific Journalism Guadalajara, Mexico November 8, 2011
Transcript
Page 1: Covering Cancer Treatments: Tricks of the Trade

Covering Cancer Treatment:Tricks of the Trade

Ivan Oransky, MDExecutive Editor, Reuters Health

Cancer Research in the MediaInter-American Workshop for Scientific Journalism

Guadalajara, MexicoNovember 8, 2011

Page 2: Covering Cancer Treatments: Tricks of the Trade

How Good is the Study?• Keep yesterday’s criteria in mind:– Peer-reviewed?– Published? Where?

• Was it in humans?– It’s remarkable there are any mice left with

cancer, depression, or restless leg syndrome

• Size matters

• Was it well-designed?

Page 3: Covering Cancer Treatments: Tricks of the Trade

From Covering Medical Research, Schwitzer/AHCJ

Page 4: Covering Cancer Treatments: Tricks of the Trade

Just Say No

Sometimes, it’s better not to cover something. But if you must…

Page 5: Covering Cancer Treatments: Tricks of the Trade

What’s Your Angle?• Are you trying to help readers, listeners, and

viewers make better health care decisions?

• Covering a study because it has a good business angle, or it’s about a local project, is perfectly OK, but it doesn’t mean readers deserve less evidence and skepticism

Page 6: Covering Cancer Treatments: Tricks of the Trade

Who Could Benefit?• How many people have the disease?

• Keep potential disease-mongering in mind

Page 7: Covering Cancer Treatments: Tricks of the Trade

How Effective is the Treatment?• Adding months, or years?

• Preventing complications? How many?

• Always remember to quantify results, not just “patients improved”

Page 8: Covering Cancer Treatments: Tricks of the Trade

What Are The Side Effects?• Every treatment has them

• Where to look:– Go beyond press releases and abstracts– Look at tables, charts, and results sections

Page 9: Covering Cancer Treatments: Tricks of the Trade

Who Dropped Out?• Why did they leave the trial?

• Intention to treat analysis

Page 10: Covering Cancer Treatments: Tricks of the Trade

How Much Does it Cost?• If it’s ready to be the subject of a story, someone

has projected the likely cost and market. – At least ask.

Page 11: Covering Cancer Treatments: Tricks of the Trade

Who Has an Interest?• Disclose conflicts

• PharmedOut.org

• Dollars For Docs series http://projects.propublica.org/docdollars/

Page 12: Covering Cancer Treatments: Tricks of the Trade

Are There Alternatives?• Did the study compare the new treatment to

existing alternatives, or to placebo?

• What are the advantages and disadvantages (and costs) of those existing alternatives?

Page 13: Covering Cancer Treatments: Tricks of the Trade

Don’t Rely Only on Study Authors• Find outside sources. Here’s how:

Page 14: Covering Cancer Treatments: Tricks of the Trade

Use Anecdotes Carefully• Is the story representative?

• Does the source of the story have any conflicts?

• More on this at today’s panel session

Page 15: Covering Cancer Treatments: Tricks of the Trade

Watch Your Language• Lifestyle/diet – are they randomized controlled

trials, or just observational?

• If observational, make the language fit the evidence:

– YES: “tied,” “linked”

– NO: “reduces,” “causes”

Page 16: Covering Cancer Treatments: Tricks of the Trade

Absolute vs. Relative Risk• Consider the risk for blindness in a patient with

diabetes over a five-year period

• The risk for blindness is 2 in 100 (2%) in people who get the conventional treatment and 1 in 100 (1%) with a new drug

• The absolute difference is derived by subtracting the lower risk from the higher risk: 2% - 1% = 1%.

From Covering Medical Research, Schwitzer/AHCJ

Page 17: Covering Cancer Treatments: Tricks of the Trade

Absolute vs. Relative Risk• Expressed as an absolute difference, the new drug

reduces the five-year risk for blindness by 1%.

• The relative difference is the ratio of the two risks.

• Given the data above, the relative difference is:

1% ÷ 2% = 50%

• Expressed as a relative difference, the new drug cuts the risk of blindness in half.

From Covering Medical Research, Schwitzer/AHCJ

Page 18: Covering Cancer Treatments: Tricks of the Trade

Number Needed To Treat• Same concept as number needed to screen

• Can be calculated from absolute risk: – 100/absolute risk difference (as a percentage)

Page 19: Covering Cancer Treatments: Tricks of the Trade

Keep Yourself Honest

• Use HealthNewsReview.org

Page 20: Covering Cancer Treatments: Tricks of the Trade

Acknowledgement/Contact• Nancy Lapid, Reuters Health

[email protected]: @ivanoransky


Recommended